advertisement
Science News
from research organizations

Liquid biopsy spots aggressive pediatric brainstem cancer earlier without surgery

Sensitive, specific analysis counts individual tumor DNA molecules left in blood and fluids

Date:
November 6, 2017
Source:
Children's National Health System
Summary:
A particularly aggressive form of pediatric cancer can be spotted reliably by the genetic fragments it leaves behind in children's biofluids, opening the door to non-surgical biopsies and providing a way to gauge whether such tumors respond to treatment, according to researchers.
Share:
FULL STORY

A particularly aggressive form of pediatric cancer can be spotted reliably by the genetic fragments it leaves behind in children's biofluids, opening the door to non-surgical biopsies and providing a way to gauge whether such tumors respond to treatment, according to an abstract presented by Children's National Health System researchers during the Society for Neuro-Oncology (SNO) 2017 Annual Meeting.

Children diagnosed with diffuse midline histone 3 K27M mutant (H3K27M) glioma face a poor prognosis with a median survival time of only nine months after the pediatric brainstem cancer is diagnosed. Right now, clinicians rely on magnetic resonance imaging (MRI) to gauge how tumors are growing, but MRI can miss very small changes in tumor size. The Children's research team led by Javad Nazarian, Ph.D., M.S.C., scientific director of Children's Brain Tumor Institute, tested whether circulating tumor DNA in patients' blood and cerebrospinal fluid would provide an earlier warning that tumors were growing. Just as a detective looks for fingerprints left at a scene, the new genetic analysis technique can detect telltale signs that tumors leave behind in body fluids.

"We continue to push the envelope to find ways to provide hope for children and families who right now face a very dismal future. By identifying these tumors when they are small and, potentially more responsive to treatment, our ultimate aim is to help children live longer," says Eshini Panditharatna, B.A., study lead author. "In addition, we are hopeful that the comprehensive panel of tests we are constructing could identify which treatments are most effective in shrinking these deadly tumors."

The researchers collected biofluid samples from 22 patients with diffuse intrinsic pontine glioma (DIPG) who were enrolled in a Phase I clinical trial. Upfront and longitudinal plasma samples were collected with each MRI at various stages of disease progression. The team developed a liquid biopsy assay using a sensitive digital droplet polymerase chain reaction system that precisely counts individual DNA molecules.

"We detected H3K27M, a major driver mutation in DIPG, in about 80 percent of cerebrospinal fluid and plasma samples," Panditharatna says. "Similar to adults with central nervous system (CNS) cancers, cerebrospinal fluid of children diagnosed with CNS cancers has high concentrations of circulating tumor DNA. However, after the children underwent radiotherapy, there was a dramatic decrease in circulating tumor DNA for 12 of the 15 patients (80 percent) whose temporal plasma was analyzed."

Nazarian, the study senior author adds: "Biofluids, like plasma and cerebrospinal fluid, are suitable media to detect and measure concentrations of circulating tumor DNA for this type of pediatric glioma. Liquid biopsy has the potential to complement tissue biopsies and MRI evaluation to provide earlier clues to how tumors are responding to treatment or recurring."

Story Source:

Materials provided by Children's National Health System. Note: Content may be edited for style and length.


Cite This Page:

Children's National Health System. "Liquid biopsy spots aggressive pediatric brainstem cancer earlier without surgery: Sensitive, specific analysis counts individual tumor DNA molecules left in blood and fluids." ScienceDaily. ScienceDaily, 6 November 2017. <www.sciencedaily.com/releases/2017/11/171106090128.htm>.
Children's National Health System. (2017, November 6). Liquid biopsy spots aggressive pediatric brainstem cancer earlier without surgery: Sensitive, specific analysis counts individual tumor DNA molecules left in blood and fluids. ScienceDaily. Retrieved February 20, 2018 from www.sciencedaily.com/releases/2017/11/171106090128.htm
Children's National Health System. "Liquid biopsy spots aggressive pediatric brainstem cancer earlier without surgery: Sensitive, specific analysis counts individual tumor DNA molecules left in blood and fluids." ScienceDaily. www.sciencedaily.com/releases/2017/11/171106090128.htm (accessed February 20, 2018).

RELATED STORIES

FROM AROUND THE WEB

Below are relevant articles that may interest you. ScienceDaily shares links and proceeds with scholarly publications in the TrendMD network.